ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,322Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 617

$609K Total Retail Price of All Prescriptions

Rank: 47 out of 617

644 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 644 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 644 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 11,402 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LISINOPRIL 520 410 1 5
OMEPRAZOLE 495 376 2 3
LEVOTHYROXINE SODIUM 487 342 3 1
SIMVASTATIN 449 356 4 2
METFORMIN HCL 382 282 5 9
METOPROLOL TARTRATE 351 298 6 11
POTASSIUM CHLORIDE 345 269 7 10
FUROSEMIDE 332 266 8 4
WARFARIN SODIUM 330 305 9 7
HYDROCODONE-ACETAMINOPHEN 324 269 S3 10 8
LOVASTATIN 303 236 11 57
SERTRALINE HCL 267 255 12 20
HYDROCHLOROTHIAZIDE 264 229 13 13
METOPROLOL SUCCINATE 224 199 14 12
AMLODIPINE BESYLATE 219 193 15 6
LOSARTAN POTASSIUM 193 181 16 22
PRAVASTATIN SODIUM 186 137 17 21
TRAMADOL HCL 183 160 18 15
ZOLPIDEM TARTRATE 182 117 19 23
ATORVASTATIN CALCIUM 171 153 20 14
ATENOLOL 170 165 21 17
ENALAPRIL MALEATE 169 129 22 34
CARVEDILOL 157 130 23 19
POLYETHYLENE GLYCOL 3350 129 78 24 32
DOXAZOSIN MESYLATE 129 107 24 79
DONEPEZIL HCL 127 113 26 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 125 105 27 29
ALENDRONATE SODIUM 125 115 27 25
CRESTOR 119 73 29 28
MELOXICAM 116 102 30 24
TRIAMTERENE-HCTZ 112 101 31 47
BISOPROLOL FUMARATE 112 112 31 100
TAMSULOSIN HCL 108 100 33 26
ALLOPURINOL 107 107 34 27
DIGOXIN 104 96 35 48
DOXYCYCLINE HYCLATE 102 83 36 113
FLUTICASONE PROPIONATE 92 84 37 36
CITALOPRAM HBR 86 85 38 18
PREDNISONE 85 55 39 31
SPIRONOLACTONE 84 69 40 42
GABAPENTIN 83 55 41 16
CYMBALTA 79 60 42 49
BUPROPION XL 75 58 43 161
OXYBUTYNIN CHLORIDE 75 60 43 88
TRAZODONE HCL 73 40 45 51
FLUOXETINE HCL 72 61 46 73
GLIMEPIRIDE 71 44 47 33
LOSARTAN-HYDROCHLOROTHIAZIDE 70 69 48 46
RANITIDINE HCL 69 69 49 40
RISPERIDONE 68 41 50 71
KLOR-CON 10 68 63 50 126
FAMOTIDINE 67 33 52 54
VENLAFAXINE HCL ER 62 60 53 76
BISOPROLOL-HYDROCHLOROTHIAZIDE 62 59 53 87
SPIRONOLACTONE-HCTZ 61 58 55 189
NAMENDA 61 61 55 35
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 52 57 91
ESCITALOPRAM OXALATE 59 29 58 65
MIRTAZAPINE 58 58 59 50
HYDRALAZINE HCL 56 52 60 164
GEMFIBROZIL 56 42 60 105
AMITRIPTYLINE HCL 54 30 R 62 56
PROPRANOLOL HCL 53 37 63 109
NADOLOL 53 34 63 310
ADVAIR DISKUS 52 48 65 38
CLOPIDOGREL 52 38 65 53
LEVETIRACETAM 52 27 65 166
SPIRIVA 52 46 65 61
INSULIN SYRINGE 51 36 69 148
PANTOPRAZOLE SODIUM 51 0 69 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.